...

DIACCURATE

Visitar página Web

Sobre el empleador

Diaccurate is a spin off from the Pasteur Institute in Paris, France. We work on a new enzymatic mechanism involved in the control of immune responses against HIV and other pathogens. Involvement of this mechanism in the control of tumor growth is also under study. We have discovered in the plasma of immunodeficient patients, a new molecule named RIF (for “Refractory state Inducing Factor”) which by modifying their membrane blocks specifically CD4 lymphocytes responses. Inhibitory monoclonal antibody neutralizing RIF has been characterized and clinical trials should start in 2018.

Ubicación de la empresa

Descubre empleadores similares

...
University of Luxembourg Luxemburgo 102 posiciones abiertas
...
KU Leuven Lovaina, Bélgica 101 posiciones abiertas
...
Ghent University Gante, Bélgica 70 posiciones abiertas
...
University of Twente Enschede, Holanda 62 posiciones abiertas
...
ETH Zürich Zúrich, Suiza 61 posiciones abiertas
Más empleadores

Esto puede ser de tu interés

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 minutos de lectura
...
The genetic detectives discovering who we really are University of Turku 5 minutos de lectura
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 minutos de lectura
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 minutos de lectura
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 minutos de lectura
Más historias